All Stocks
L

LQDA

Liquidia Corporation
Healthcare›Biotechnology|NASDAQ Capital Market|US

Price

$37.68

Market Cap

$3.32B

Beta

0.56

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+1031.18%
EPS Growth (YoY)+49.95%
Revenue CAGR 3Y+114.98%
P/E Ratio0.0
PEG Ratio—
FCF Yield-1.21%
Debt / Equity4.42
Interest Coverage-2.1x

Sign up free to unlock full analysis

  • ✓Full 24-factor quality scorecard
  • ✓AI investment committee analysis
  • ✓Factor radar & value trap detection
  • ✓10-year strategy backtesting
  • ✓Advanced screening & filtering
Get started free

No credit card required

Already have an account? Sign in to view the full analysis for LQDA.